Cell Counting Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

The Cell Counting Market is Segmented by Product Type (Instruments and Consumables), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Cell Counting Market Size

Cell Counting Market Summary
share button
Study Period 2018-2028
Base Year For Estimation 2022
Forecast Data Period 2023 - 2028
CAGR 7.20 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Cell Counting Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Cell Counting Market Analysis

Over the next few years, the cell counting market is expected to register a CAGR of 7.2%.

COVID-19 had a significant impact on the adoption of cell-counting products and consumables. The pandemic witnessed increased adoption of cell counting devices, as osteopenia and lymphopenia were the potential indicators of COVID-19. The study, published in BMC Infectious Diseases in June 2021, found that in COVID-19 patients, a high WBC count upon admission was significantly linked to death. As a result, in the therapy of COVID-19, a higher WBC count should be given more consideration. Thus, the COVID-19 pandemic had a pronounced impact on the growth of the market. However, as the pandemic has subsided currently, the market is expected to experience stable growth over the forecast period of the study.

The major factors contributing to the market's growth are the rising incidence of target diseases like HIV, measles, diphtheria, and chronic diseases like cancer and other blood disorders; and the growing use of high-throughput flow cytometry and automated hematology analyzers.

According to the data from UNAIDS, in 2022, an estimated 38.4 million people worldwide were living with HIV, and an estimated 1.5 million people became newly infected with HIV in 2021. It was also stated that by 2021, 28.7 million people would have access to antiretroviral therapy. Thus, rising cases of infectious diseases are ultimately expected to increase the demand for cell counting products and consumables.

Furthermore, technological advancements in cell counting products and consumables have led to increased product launches and, thereby, increased adoption, in turn driving market growth. For instance, Logos Biosystems, a leading provider of cutting-edge life science solutions and a division of Aligned Genetics, Inc., officially launched the CountWire System in February 2021.

Therefore, the rising prevalence of chronic diseases, growing technological advancements, and product launches in the cell counting market, among others, are expected to drive the growth of this market. But the growth of the market is likely to be slowed by the high cost of advanced cell counting systems and product recalls of hematology analyzers.

Cell Counting Market Trends

This section covers the major market trends shaping the Cell Counting Market according to our research experts:

The Instruments Segment is Expected to Hold a Significant Share Over the Forecast Period.

The instruments segment is expected to hold a significant share over the forecast period due to factors such as the increasing usage of cell counters in various applications like research, diagnostics, and industrial. Cell counting instruments are increasingly being adopted in various research areas, such as cancer biology, immunology, and neuroscience, which displays exponential growth opportunities for the market segment.

According to the study published by PubMed Central in November 2021, a new cell counter called RapID Cell Counter was analyzed. It is a semi-automated cell-counting tool with an easy-to-implement graphical user interface (GUI), and it is able to facilitate quick and consistent quantifications of cell density within user-defined boundaries that can be divided into equally partitioned segments. The importance and efficiency of cell counter instruments will lead to increased demand for these instruments, which is expected to propel the instrument segment's growth over the coming years.

Furthermore, rising initiatives from the key market players to launch advanced cell counter devices have led to increased adoption of these devices due to their diverse applications and ease of workflow. For instance, in June 2021, CytoSMART Technologies introduced one of the first fluorescent cell counters. The CytoSMART Exact FL is a fully automated dual fluorescence cell counter with artificial intelligence (AI)-powered image recognition algorithms.The rise in product advancements will lead to higher adoption, thereby driving this segment's growth. Moreover, the rising prevalence of cancer is one of the major factors driving the growth of the segment, as cell counters are being increasingly used in oncology.

Therefore, due to factors such as increasing adoption in various research areas, such as cancer biology, immunology, and neuroscience, and rising initiatives from the key market players to launch advanced cell counter devices, the instruments segment is expected to experience growth over the forecast period.

Cell Counting Market - Estimated New Cases of Leukemia (In Thousands), By Gender, United States, 2022

North America Holds a Significant Share in the Market and is Expected to do Same in the Forecast Period

North America holds a significant share of the market and is expected to do the same in the overall cell counting market throughout the forecast period. The large share of the market is mostly due to the fact that there are more patients, more healthcare settings are using high-throughput flow cytometry and automated hematology analyzers, and key players are based in the region.

The United States holds a significant market share in the North American region due to factors such as the increasing number of chronic diseases and the growing number of research and development activities in the country. According to the American Cancer Society's 2022 statistics, in the United States, there will be 290,560 new cases of breast cancer, 268,490 new cases of prostate cancer, and 236,740 new cases of lung and bronchial cancer in 2022. Such a high burden of cancer creates the need for a proper diagnosis and thus drives the growth of the market in the region.

Furthermore, according to the data published by the Canadian Cancer Society in November 2022, an estimated 233,900 people will be diagnosed with cancer in 2022. This growth in incidence is mainly due to Canada's growing and aging population and emphasizes the importance of cancer prevention. The high prevalence of cancer in Canada is also expected to increase the demand for cell counters, thus driving the market's growth.

Furthermore, the rise in product launches by companies in the United States will further lead to increased adoption of these devices, thereby propelling the growth of this market in North America. For instance, in August 2021, BD (Becton, Dickinson, and Company), a United States-based medical devices company, launched a new benchtop cell analyzer that brings sophisticated flow cytometry capabilities to laboratories of all sizes.

Therefore, owing to the above factors, such as the rise in product launches by companies and the increasing prevalence of diseases like cancer in the region, the North American region is expected to show significant growth over the forecast period.

Cell Counting Market - Growth Rate by Region

Cell Counting Industry Overview

The cell counting market is moderately competitive. A few of the crucial approaches followed by players are product advancement, invention, acquisitions, and mergers. Some of the companies currently dominating the market are Danaher Corporation, Thermo Fisher Scientific, Becton, Dickinson and Company, Merck, Bio-Rad Laboratories, and GE Healthcare, among others.

Cell Counting Market Leaders

  1. Thermo Fisher Scientific

  2. Becton, Dickinson and Company

  3. Bio-Rad Laboratories

  4. Merck KGaA

  5. Danaher Corporation (Beckman Coulter, Inc.)

*Disclaimer: Major Players sorted in no particular order

Cell Counting Market Concentration

Cell Counting Market News

  • March 2022: Mindray launched the new BC-700 Series, a revolutionary hematology analyzer series that incorporates complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests.
  • February 2022: Abacus dx entered into a new partnership with Luminex for their Guava range of flow cytometry instruments and reagents. As part of the deal, Luminex's Guava line of flow cytometry instruments and reagents will be sold by Abacus dx.

Cell Counting Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Incidence of Target Diseases and Blood Disorders

      2. 4.2.2 Growing Use of High-throughput Flow Cytometry and Automated Hematology Analyzers

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Advanced Cell Counting Systems and Product Recalls of Hematology Analyzers

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Product Type

      1. 5.1.1 Instruments

        1. 5.1.1.1 Spectrophotometers

        2. 5.1.1.2 Flow Cytometers

        3. 5.1.1.3 Hematology Analyzers

        4. 5.1.1.4 Cell Counters

      2. 5.1.2 Consumables

        1. 5.1.2.1 Media, Sera, and Reagents

        2. 5.1.2.2 Assay Kits

        3. 5.1.2.3 Other Consumables

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States

        2. 5.2.1.2 Canada

        3. 5.2.1.3 Mexico

      2. 5.2.2 Europe

        1. 5.2.2.1 Germany

        2. 5.2.2.2 United Kingdom

        3. 5.2.2.3 France

        4. 5.2.2.4 Italy

        5. 5.2.2.5 Spain

        6. 5.2.2.6 Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. 5.2.3.1 China

        2. 5.2.3.2 Japan

        3. 5.2.3.3 India

        4. 5.2.3.4 Australia

        5. 5.2.3.5 South Korea

        6. 5.2.3.6 Rest of Asia-Pacific

      4. 5.2.4 Middle East and Africa

        1. 5.2.4.1 GCC

        2. 5.2.4.2 South Africa

        3. 5.2.4.3 Rest of Middle East and Africa

      5. 5.2.5 South America

        1. 5.2.5.1 Brazil

        2. 5.2.5.2 Argentina

        3. 5.2.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Danaher Corporation (Beckman Coulter Inc.)

      2. 6.1.2 Thermo Fisher Scientific Inc.

      3. 6.1.3 Becton, Dickinson and Company

      4. 6.1.4 Merck KGaA

      5. 6.1.5 Bio-Rad Laboratories Inc.

      6. 6.1.6 GE Healthcare

      7. 6.1.7 Agilent Technologies Inc.

      8. 6.1.8 F. Hoffmann-La Roche

      9. 6.1.9 Siemens Healthineers AG

      10. 6.1.10 DeNovix Inc.

      11. 6.1.11 PerkinElmer Inc.

      12. 6.1.12 Tecan Group AG

      13. 6.1.13 Sysmex Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

Cell Counting Industry Segmentation

As per the scope of the report, cell counting plays a vital role in cell analysis; it helps identify the viability of cells and cell growth; and it quantifies the number of live or dead cells in cell culture. The Cell Counting market is segmented by Product Type (Instruments (Spectrophotometers, Flow Cytometers, Hematology Analyzers, and Cell Counters) and Consumables (Media, Sera, and Reagents, Assay Kits, and Other Consumables)) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Type
Instruments
Spectrophotometers
Flow Cytometers
Hematology Analyzers
Cell Counters
Consumables
Media, Sera, and Reagents
Assay Kits
Other Consumables
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Cell Counting Market Research FAQs

The Cell Counting Market is projected to register a CAGR of 7.2% during the forecast period (2023-2028).

Thermo Fisher Scientific, Becton, Dickinson and Company, Bio-Rad Laboratories, Merck KGaA and Danaher Corporation (Beckman Coulter, Inc.) are the major companies operating in the Cell Counting Market.

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2023-2028).

In 2023, the North America accounts for the largest market share in the Cell Counting Market.

Cell Counting Industry Report

Statistics for the 2023 Cell Counting market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Cell Counting analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!